Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option

We describe a case of a 46-year-old woman diagnosed with localized PTC 20 years ago, having already undergone several treatments with iodine-131 and then treatment with lenvatinib for metastatic disease, to which she developed intolerance. In 2020, in addition to pleural, thoracic, and abdominal lym...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis, Joana S., Costa, Inês, Costa, Mariana, Valente, Ana Carmo, Freitas, Marta Baptista, Almeida, Catarina Lopes, Gonçalves, Marina, Teixeira, Carina, Ribeiro, Maria, Caeiro, Cláudia, Fernandes, Catarina, Barbosa, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830316/
https://www.ncbi.nlm.nih.gov/pubmed/36636677
http://dx.doi.org/10.1159/000526533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830316/
https://www.ncbi.nlm.nih.gov/pubmed/36636677
http://dx.doi.org/10.1159/000526533

Ejemplares similares